CIBC Asset Management’s Nektar Therapeutics NKTR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-956
| Closed | -$32.4K | – | 1111 |
|
|
2022
Q4 | $32.4K | Sell |
956
-105
| -10% | -$3.56K | ﹤0.01% | 1038 |
|
|
2022
Q3 | $51K | Hold |
1,061
| – | – | ﹤0.01% | 1207 |
|
|
2022
Q2 | $60K | Sell |
1,061
-38
| -3% | -$2.15K | ﹤0.01% | 1223 |
|
|
2022
Q1 | $89K | Hold |
1,099
| – | – | ﹤0.01% | 1466 |
|
|
2021
Q4 | $223K | Buy |
+1,099
| New | +$223K | ﹤0.01% | 1309 |
|
|
2019
Q4 | – | Sell |
-935
| Closed | -$256K | – | 1226 |
|
|
2019
Q3 | $256K | Sell |
935
-2
| -0.2% | -$548 | ﹤0.01% | 908 |
|
|
2019
Q2 | $500K | Buy |
937
+27
| +3% | +$14.4K | ﹤0.01% | 742 |
|
|
2019
Q1 | $459K | Sell |
910
-13
| -1% | -$6.56K | ﹤0.01% | 745 |
|
|
2018
Q4 | $455K | Buy |
923
+2
| +0.2% | +$986 | ﹤0.01% | 704 |
|
|
2018
Q3 | $842K | Sell |
921
-7
| -0.8% | -$6.4K | 0.01% | 627 |
|
|
2018
Q2 | $679K | Buy |
928
+39
| +4% | +$28.5K | ﹤0.01% | 666 |
|
|
2018
Q1 | $1.42M | Buy |
889
+528
| +146% | +$842K | 0.01% | 491 |
|
|
2017
Q4 | $323K | Sell |
361
-388
| -52% | -$347K | ﹤0.01% | 799 |
|
|
2017
Q3 | $270K | Buy |
749
+58
| +8% | +$20.9K | ﹤0.01% | 834 |
|
|
2017
Q2 | $203K | Hold |
691
| – | – | ﹤0.01% | 920 |
|
|
2017
Q1 | $243K | Hold |
691
| – | – | ﹤0.01% | 844 |
|
|
2016
Q4 | $127K | Buy |
+691
| New | +$127K | ﹤0.01% | 927 |
|